Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphotericin B target-site concentration study in critically ill patients
2007-001795-37Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amphotericin b in invasive mycoses, sponsored by Medical University of Innsbruck. Primary endpoints: Plasma concentration, Ascites concentration and 3 more. Started Jun 2007; status: completed.
02
Drugs
amphotericin b
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2007-001795-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001795-37.